• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量CT形态计量学:一种预测膀胱癌分级的新方法。

Quantitative CT Morphometrics: A Novel Approach for Predicting the Bladder Cancer Grade.

作者信息

Eroglu Tolga, Köseoğlu Hikmet, Yücetaş Uğur, Ari Emre, Kadihasanoglu Mustafa

机构信息

Urology, Antalya City Hospital, Antalya, TUR.

Urology, Health Sciences University, Taksim Training and Research Hospital, Istanbul, TUR.

出版信息

Cureus. 2024 Jun 28;16(6):e63427. doi: 10.7759/cureus.63427. eCollection 2024 Jun.

DOI:10.7759/cureus.63427
PMID:39077224
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11284344/
Abstract

Background and objective Bladder cancer (BC) is a common urothelial neoplasm, with non-muscle invasive forms comprising about 75% of cases and generally having better outcomes than muscle-invasive types. Accurate preoperative grading and staging of BC are essential for appropriate treatment planning. This study investigates the efficacy of computerized tomography (CT) in correlating the morphological features of tumors to predict the histopathological grades of BC.  Materials and methods This retrospective cohort involved 100 patients diagnosed with non-muscle invasive BC, who underwent transurethral resection of bladder tumor (TUR-BT) between January 2010 and August 2021. CT imaging, utilizing a 128-slice CT scanner, was employed to measure the tumor height (H) and contact length (CL). The study considered morphometric parameters across axial, coronal, and sagittal planes. Statistical analyses were conducted, comparing radiological findings with histopathological evaluations. Tumor grading was determined according to the 2004/2016 WHO classification. Results Among the 100 patients with primary bladder tumors, 15 were female and 85 were male, with a mean age of 65.28 ± 7.11 years. Furthermore, 58 had high-grade bladder tumors, while 42 had low-grade bladder tumors. Across all planes, high-grade tumors exhibited higher values for the tumor H, CL, and the tumor height-to-contact length (H/CL) ratio compared to low-grade tumors (p<0.05). Notably, the specificity, sensitivity, and diagnostic accuracy of the tumor CL were higher than those of the tumor H and the tumor H/CL ratio. A tumor CL exceeding 19.1mm measured in the axial plane demonstrated 83% sensitivity and specificity for high-grade tumors. Conclusion The measured CL of the tumor in the axial plane on computerized tomography urography has high sensitivity and specificity in detecting high-grade tumors.

摘要

背景与目的

膀胱癌(BC)是一种常见的尿路上皮肿瘤,非肌层浸润性形式约占病例的75%,其预后通常比肌层浸润性类型更好。准确的膀胱癌术前分级和分期对于制定合适的治疗方案至关重要。本研究调查计算机断层扫描(CT)在关联肿瘤形态学特征以预测膀胱癌组织病理学分级方面的有效性。

材料与方法

本回顾性队列研究纳入了100例诊断为非肌层浸润性膀胱癌的患者,这些患者在2010年1月至2021年8月期间接受了经尿道膀胱肿瘤切除术(TUR-BT)。使用128层CT扫描仪进行CT成像,测量肿瘤高度(H)和接触长度(CL)。该研究考虑了轴位、冠状位和矢状位平面的形态计量学参数。进行了统计分析,将放射学结果与组织病理学评估进行比较。肿瘤分级根据2004/2016年世界卫生组织分类确定。

结果

在100例原发性膀胱肿瘤患者中,女性15例,男性85例,平均年龄为65.28±7.11岁。此外,58例为高级别膀胱肿瘤,42例为低级别膀胱肿瘤。在所有平面上,与低级别肿瘤相比,高级别肿瘤的肿瘤H、CL以及肿瘤高度与接触长度(H/CL)比值更高(p<0.05)。值得注意的是,肿瘤CL的特异性、敏感性和诊断准确性高于肿瘤H和肿瘤H/CL比值。在轴位平面上测量的肿瘤CL超过19.1mm对高级别肿瘤的敏感性和特异性为83%。

结论

计算机断层扫描尿路造影中轴位平面上测量的肿瘤CL在检测高级别肿瘤方面具有高敏感性和特异性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283c/11284344/9803589b9211/cureus-0016-00000063427-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283c/11284344/5515a0d6b34d/cureus-0016-00000063427-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283c/11284344/aaf89d625a6e/cureus-0016-00000063427-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283c/11284344/5b28605a402f/cureus-0016-00000063427-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283c/11284344/9803589b9211/cureus-0016-00000063427-i04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283c/11284344/5515a0d6b34d/cureus-0016-00000063427-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283c/11284344/aaf89d625a6e/cureus-0016-00000063427-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283c/11284344/5b28605a402f/cureus-0016-00000063427-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/283c/11284344/9803589b9211/cureus-0016-00000063427-i04.jpg

相似文献

1
Quantitative CT Morphometrics: A Novel Approach for Predicting the Bladder Cancer Grade.定量CT形态计量学:一种预测膀胱癌分级的新方法。
Cureus. 2024 Jun 28;16(6):e63427. doi: 10.7759/cureus.63427. eCollection 2024 Jun.
2
Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study.非肌层浸润性高级别膀胱癌二次经尿道切除术的临床结局:一项回顾性、多机构协作研究
Int J Clin Oncol. 2017 Apr;22(2):353-358. doi: 10.1007/s10147-016-1048-z. Epub 2016 Oct 15.
3
A new tool for distinguishing muscle invasive and non-muscle invasive bladder cancer: the initial application of flexible ultrasound bronchoscope in bladder tumor staging.一种区分肌肉浸润性和非肌肉浸润性膀胱癌的新工具:可弯曲超声支气管镜在膀胱肿瘤分期中的初步应用
PLoS One. 2014 Apr 4;9(4):e92385. doi: 10.1371/journal.pone.0092385. eCollection 2014.
4
Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.再次经尿道膀胱肿瘤切除术(re-cTURBT)作为pT1期高级别(HG)疾病复发和进展的风险指标是否有用?一项单中心经验。
Arch Ital Urol Androl. 2017 Dec 31;89(4):272-276. doi: 10.4081/aiua.2017.4.272.
5
Higher Serum Endothelial-Specific Molecule-1 (ESM-1/Endocan) Levels are Associated with Poor Pathological Outcomes in Primary Bladder Cancer: A Non-randomized, Prospective, Case-Control Study.血清内皮特异性分子-1(ESM-1/Endocan)水平升高与原发性膀胱癌不良病理结局相关:一项非随机、前瞻性、病例对照研究。
Arch Esp Urol. 2023 Mar;76(2):132-138. doi: 10.56434/j.arch.esp.urol.20237602.14.
6
[The impact of restaging transurethral resection on recurrence and progression free survival in patients with T1 high grade bladder cancer].[再分期经尿道切除术对T1期高级别膀胱癌患者无复发生存率和无进展生存率的影响]
Prog Urol. 2023 Mar;33(3):125-134. doi: 10.1016/j.purol.2022.12.012. Epub 2023 Jan 4.
7
Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.对于新诊断的非肌层浸润性膀胱癌,单次广泛经尿道切除术后联合适当的膀胱内灌注治疗的肿瘤学结局。
Int Urol Nephrol. 2015 Sep;47(9):1509-14. doi: 10.1007/s11255-015-1048-3. Epub 2015 Jul 7.
8
A new parameter for staging bladder carcinoma: ultrasonographic contact length and height-to-length ratio.膀胱癌分期的一个新参数:超声接触长度及高长比
J Ultrasound Med. 2007 Sep;26(9):1137-42. doi: 10.7863/jum.2007.26.9.1137.
9
Predicting the Lymphovascular Invasion in Carcinoma Bladder at Transurethral Resection.经尿道膀胱肿瘤电切术中预测膀胱癌的淋巴管侵犯情况
Cureus. 2024 Jun 18;16(6):e62595. doi: 10.7759/cureus.62595. eCollection 2024 Jun.
10
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.

引用本文的文献

1
Precise vesical wall staging of bladder cancer in the era of precision medicine: has it been fulfilled?精准医学时代膀胱癌的膀胱壁精确分期:是否已经实现?
Abdom Radiol (NY). 2024 Dec 27. doi: 10.1007/s00261-024-04786-8.

本文引用的文献

1
Bladder cancer grading using the four-tier combination of the World Health Organization (WHO) 1973 and WHO 2004 classifications.膀胱癌分级采用世界卫生组织(WHO)1973 年和 2004 年分类的四层组合。
BJU Int. 2023 Dec;132(6):656-663. doi: 10.1111/bju.16100. Epub 2023 Jul 12.
2
Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage.非肌层浸润性膀胱癌的辅助治疗:卡介苗短缺期间的进展
World J Urol. 2022 May;40(5):1111-1124. doi: 10.1007/s00345-021-03908-x. Epub 2022 Jan 27.
3
Artificial intelligence: A promising frontier in bladder cancer diagnosis and outcome prediction.
人工智能:膀胱癌诊断和预后预测的有前景的前沿领域。
Crit Rev Oncol Hematol. 2022 Mar;171:103601. doi: 10.1016/j.critrevonc.2022.103601. Epub 2022 Jan 19.
4
Investigation of Synthetic Magnetic Resonance Imaging Applied in the Evaluation of the Tumor Grade of Bladder Cancer.合成磁共振成像在膀胱癌肿瘤分级评估中的应用研究
J Magn Reson Imaging. 2021 Dec;54(6):1989-1997. doi: 10.1002/jmri.27770. Epub 2021 Jun 3.
5
Diagnosis and Staging of Bladder Cancer.膀胱癌的诊断和分期。
Hematol Oncol Clin North Am. 2021 Jun;35(3):531-541. doi: 10.1016/j.hoc.2021.02.004. Epub 2021 Apr 15.
6
Cancer statistics for the year 2020: An overview.2020年癌症统计数据概述。
Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588.
7
Bladder Cancer: A Review.膀胱癌:综述。
JAMA. 2020 Nov 17;324(19):1980-1991. doi: 10.1001/jama.2020.17598.
8
CT-based radiomics to predict the pathological grade of bladder cancer.基于 CT 的放射组学预测膀胱癌病理分级。
Eur Radiol. 2020 Dec;30(12):6749-6756. doi: 10.1007/s00330-020-06893-8. Epub 2020 Jun 29.
9
Advances in risk stratification of bladder cancer to guide personalized medicine.膀胱癌风险分层以指导个性化医疗的进展。
F1000Res. 2018 Jul 25;7. doi: 10.12688/f1000research.14903.1. eCollection 2018.
10
Artificial intelligence in radiology.人工智能在放射学中的应用。
Nat Rev Cancer. 2018 Aug;18(8):500-510. doi: 10.1038/s41568-018-0016-5.